Skip to content
healthcare.dev
Get a free key

Neostigmine methylsulfate

NDC 71839-106, Neostigmine methylsulfate, injection, from BE Pharmaceuticals Inc..

Product NDC
71839-106
Status
Listed
Labeler
BE Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212512
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71839-106 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
71839-106-107183901061010 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10) / 10 mL in 1 VIAL, MULTI-DOSE
71839-106-247183901062424 CARTON in 1 CARTON (71839-106-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-106-01) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/971713db-d5ac-44c1-ada5-a56a943d79bf

Use it

Look up 71839-106 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71839-106 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71839-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.